Table 2 Comparisons of clinical and echocardiographic parameters in HDL-C/hsCRP quartile groups
| Â | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P value |
|---|---|---|---|---|---|
Male gender (n/%) | 22/43.1 | 21/41.2 | 20/39.2 | 21/41.2 | 0.983 |
Age (years) | 61.0 ± 10.3 | 60.1 ± 12.0 | 59.3 ± 9.1 | 60.4 ± 9.6 | 0.861 |
Current smoker (n/%) | 17/33.3 | 14/27.5 | 14/27.5 | 14/27.5 | 0.886 |
Statin use (n/%) | 47/92.2 | 39/76.5 | 38/74.5 | 39/76.5 | 0.092 |
Other lipid regulator use (n/%) | 9/17.6 | 6/11.8 | 7/13.7 | 8/15.7 | 0.854 |
ACE inhibitor use (n/%) | 23/45.1 | 27/52.9 | 18/35.3 | 24/47.1 | 0.344 |
β blocker use (n/%) | 28/54.9 | 24/47.1 | 25/49.0 | 26/51.0 | 0.876 |
SBp (mmHg) | 142.6 ± 19.9 | 140.7 ± 20.7 | 141.9 ± 25.5 | 141.8 ± 25.3 | 0.981 |
DBp (mmHg) | 84.8 ± 13.9 | 81.9 ± 16.7 | 81.7 ± 15.1 | 84.0 ± 15.5 | 0.674 |
BMI (kg/m2) | 26.67 ± 2.93 | 25.92 ± 3.00 | 24.80 ± 2.33 | 23.32 ± 2.17 | 0.000 |
FPG (mmol/L) | 6.15 ± 1.70 | 6.07 ± 1.93 | 5.43 ± 1.13 | 5.90 ± 2.48 | 0.215 |
HbA1C (%) | 6.20 ± 0.97 | 6.34 ± 1.30 | 5.87 ± 1.23 | 5.94 ± 0.82 | 0.112 |
TC (mmol/L) | 4.70 ± 1.21 | 4.93 ± 1.07 | 4.49 ± 0.87 | 4.87 ± 0.98 | 0.136 |
LDL-C (mmol/L) | 3.07 ± 1.05 | 3.12 ± 0.86 | 2.90 ± 0.78 | 3.05 ± 0.87 | 0.625 |
TG (mmol/L) | 2.04 ± 1.26 | 2.19 ± 2.12 | 1.56 ± 0.65 | 1.34 ± 1.10 | 0.006 |
UA (umol/L) | 332.2 ± 71.9 | 311.1 ± 71.7 | 313.3 ± 94.6 | 282.2 ± 61.3 | 0.013 |
Cys C (mg/L) | 0.86 ± 0.21 | 0.81 ± 0.18 | 0.83 ± 0.15 | 0.83 ± 0.24 | 0.684 |
LA (mm) | 35.6 ± 2.9 | 36.1 ± 3.5 | 36.0 ± 4.2 | 34.4 ± 4.3 | 0.113 |
e' (cm/s) | 6.9 ± 1.9 | 7.0 ± 1.9 | 6.8 ± 1.9 | 7.7 ± 2.1 | 0.090 |
E/e' | 11.41 ± 2.91 | 11.98 ± 3.04 | 11.43 ± 3.36 | 10.14 ± 2.87 | 0.020 |
E/A | 0.85 ± 0.31 | 0.93 ± 0.28 | 0.86 ± 0.29 | 0.87 ± 0.30 | 0.500 |
LVEF (%) | 63.6 ± 4.2 | 63.6 ± 4.5 | 64.7 ± 3.6 | 63.6 ± 3.4 | 0.433 |